MBX BIOSCIENCES INC (MBX:NASDAQ)
$31.58 0.11 (0.3495%)
Analysed MBX BIOSCIENCES INC (MBX:NASDAQ) News Sources
MBX Biosciences to Host In-Person and Virtual Obesity Day on May 11, 2026 to Discuss Expanding Obesity Portfolio
23-04-2026
yahoo.com
3 Overlooked Stocks Set to Soar in 2026
05-05-2026
fool.com
MBX Biosciences Announces Appointment of Mark Soued as Chief Commercial Officer and Inducement Grant Award
07-05-2026
yahoo.com
MBX Biosciences Reports First Quarter 2026 Financial Results and Corporate Highlights
07-05-2026
yahoo.com
MBX Biosciences Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing
11-05-2026
yahoo.com
MBX Biosciences Obesity Day Spotlights Monthly GLP-1 Hope and Pipeline Push
11-05-2026
marketbeat.com
Insider Stock Buying Reaches US$1.06m On MBX Biosciences
15-05-2026
yahoo.com
MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City
26-05-2026
yahoo.com
Chief Medical Officer Sells MBX for $2.7 Million After Monster 2026 Run
27-05-2026
fool.com
MBX Biosciences to Host Virtual Investor Event to Discuss Once-Weekly Canvuparatide Presentations at ENDO 2026
01-06-2026
yahoo.com
What is the current price of MBX BIOSCIENCES INC (MBX:NASDAQ)?
The current price of MBX BIOSCIENCES INC (MBX:NASDAQ) is $31.58.
MBX BIOSCIENCES INC (MBX:NASDAQ) absolute price change since previous trading day?
The absolute price change of MBX BIOSCIENCES INC (MBX:NASDAQ) since the previous trading day is $0.11.
MBX BIOSCIENCES INC (MBX:NASDAQ) percentage price change since previous trading day?
The percentage price change of MBX BIOSCIENCES INC (MBX:NASDAQ) since the previous trading day is 0.3495%.
What is the most recent average sentiment score for MBX BIOSCIENCES INC (MBX:NASDAQ)?
The most recent average sentiment score for MBX BIOSCIENCES INC (MBX:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for MBX BIOSCIENCES INC (MBX:NASDAQ)?
The most recent sentiment for MBX BIOSCIENCES INC (MBX:NASDAQ) is .
SEC-8K** Filing Available For MBX BIOSCIENCES INC (MBX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.